George Cole Jr.

George Cole Jr. has extensive work experience in the pharmaceutical and biotech industry. George is currently the Vice President of Clinical Development at Nurix Therapeutics, a position they have held since April 2023. Prior to that, they worked at Nuvation Bio as the Vice President of Clinical Development from June 2022 to March 2023. George also served as the Executive Medical Director at Nektar Therapeutics from September 2021 to May 2022, and as the Senior Medical Director at AbbVie from February 2020 to August 2021. Previously, they held various medical and clinical development roles at Pharmacyclics, Gilead Sciences, Miltenyi Biotec, and the Cleveland Clinic. Additionally, George Cole Jr. has been a member of the Scientific Advisory Board at Certare Ventures, LLP since January 1996. George was also a finalist in Class 15 of the Kauffman Fellows Program from November 2009 to November 2012.

George Cole Jr. obtained a BA in Economics from Yale University in 1988. George then went on to receive an MD from Yale University School of Medicine between 1989 and 1994. Prior to their undergraduate studies, George Cole Jr. earned a diploma from the University of Chicago Laboratory Schools in 1984. There is no information available regarding their enrollment or degree from The University of Chicago Booth School of Business.